JP2019193662A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019193662A5 JP2019193662A5 JP2019129161A JP2019129161A JP2019193662A5 JP 2019193662 A5 JP2019193662 A5 JP 2019193662A5 JP 2019129161 A JP2019129161 A JP 2019129161A JP 2019129161 A JP2019129161 A JP 2019129161A JP 2019193662 A5 JP2019193662 A5 JP 2019193662A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- newcastle disease
- disease virus
- attenuated newcastle
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361873039P | 2013-09-03 | 2013-09-03 | |
| US61/873,039 | 2013-09-03 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016537333A Division JP6557234B2 (ja) | 2013-09-03 | 2014-09-02 | 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019193662A JP2019193662A (ja) | 2019-11-07 |
| JP2019193662A5 true JP2019193662A5 (enExample) | 2020-02-27 |
| JP6862500B2 JP6862500B2 (ja) | 2021-04-21 |
Family
ID=51492938
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016537333A Active JP6557234B2 (ja) | 2013-09-03 | 2014-09-02 | 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法 |
| JP2019129161A Expired - Fee Related JP6862500B2 (ja) | 2013-09-03 | 2019-07-11 | 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016537333A Active JP6557234B2 (ja) | 2013-09-03 | 2014-09-02 | 弱毒化ニューカッスル病ウイルスを特徴とする組成物並びに新生物を治療するための使用方法 |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US10519426B2 (enExample) |
| EP (3) | EP3508209B1 (enExample) |
| JP (2) | JP6557234B2 (enExample) |
| KR (2) | KR102285894B1 (enExample) |
| CN (2) | CN111944767A (enExample) |
| AU (2) | AU2014317215C1 (enExample) |
| CA (1) | CA2922071C (enExample) |
| CY (2) | CY1121993T1 (enExample) |
| DK (2) | DK3041490T3 (enExample) |
| EA (2) | EA039404B1 (enExample) |
| ES (2) | ES2914577T3 (enExample) |
| HK (2) | HK1231393A1 (enExample) |
| HR (2) | HRP20190250T1 (enExample) |
| HU (1) | HUE042382T2 (enExample) |
| LT (2) | LT3041490T (enExample) |
| ME (1) | ME03345B (enExample) |
| MX (2) | MX367768B (enExample) |
| PL (2) | PL3041490T3 (enExample) |
| PT (2) | PT3508209T (enExample) |
| RS (2) | RS63291B1 (enExample) |
| SI (2) | SI3041490T1 (enExample) |
| SM (2) | SMT202200214T1 (enExample) |
| TR (1) | TR201902073T4 (enExample) |
| TW (1) | TWI653334B (enExample) |
| WO (1) | WO2015032755A1 (enExample) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI531652B (zh) | 2005-12-02 | 2016-05-01 | 美國紐約大學西奈山醫學院 | 表現非原生表面蛋白質之嵌合病毒及其用途 |
| ES2550179T3 (es) | 2009-02-05 | 2015-11-05 | Icahn School Of Medicine At Mount Sinai | Virus quiméricos de la enfermedad de Newcastle y usos de los mismos |
| NZ711946A (en) | 2013-03-14 | 2020-05-29 | Icahn School Med Mount Sinai | Newcastle disease viruses and uses thereof |
| EA039404B1 (ru) * | 2013-09-03 | 2022-01-24 | Медиммун Лимитед | Аттенуированный вирус ньюкаслской болезни (ndv) штамма 73т для лечения неоплазии, способ селективного цитолиза опухолевых клеток и способ индуцирования регресса опухоли с его использованием |
| CA2940570A1 (en) | 2014-02-27 | 2015-09-03 | Viralytics Limited | Combination method for treatment of cancer |
| WO2016176510A1 (en) * | 2015-04-28 | 2016-11-03 | University Of Georgia Research Foundation, Inc. | Piv5-based amplifying virus-like particles |
| CA3010987A1 (en) | 2016-01-08 | 2017-07-13 | Replimune Limited | Oncolytic herpes simplex virus type 1 strain |
| EP3246410A1 (en) | 2016-05-19 | 2017-11-22 | Klinikum rechts der Isar der Technischen Universität München | Vsv/ndv hybrid viruses for oncolytic therapy of cancer |
| GB201700350D0 (en) | 2017-01-09 | 2017-02-22 | Replimune Ltd | Altered virus |
| KR101964610B1 (ko) * | 2017-03-13 | 2019-04-03 | 대한민국 | 신규한 종양용해성 바이러스 및 이의 용도 |
| JOP20190256A1 (ar) * | 2017-05-12 | 2019-10-28 | Icahn School Med Mount Sinai | فيروسات داء نيوكاسل واستخداماتها |
| CN107254450A (zh) * | 2017-07-20 | 2017-10-17 | 扬州大学 | 克服鸡新城疫母源抗体影响的嵌合新城疫病毒疫苗载体候选株及构建方法 |
| CN108486279A (zh) * | 2017-09-21 | 2018-09-04 | 山东省农业科学院家禽研究所 | 一种基于荧光定量pcr技术检测鸽新城疫病毒的方法 |
| EP3552608A1 (en) * | 2018-04-09 | 2019-10-16 | Rapo Yerape B.H. Ltd | Increased activity of oncoloytic newcastle disease virus |
| WO2020014591A1 (en) * | 2018-07-13 | 2020-01-16 | Icahn School Of Medicine At Mount Sinai | Apmv and uses thereof for the treatment of cancer |
| WO2020037215A1 (en) | 2018-08-17 | 2020-02-20 | Icahn School Of Medicine At Mount Sinai | Recombinant newcastle disease viruses and uses thereof for the prevention of rsv disease or human metapneumovirus disease |
| CN110859968A (zh) * | 2019-11-21 | 2020-03-06 | 四川安可康生物医药有限公司 | 激活对肿瘤的系统免疫反应的基因生物药物 |
| KR20230069042A (ko) * | 2020-03-20 | 2023-05-18 | 오나 테라퓨틱스, 인코포레이티드 | 원형 rna 조성물 및 방법 |
| CN115197949A (zh) * | 2021-04-13 | 2022-10-18 | 江苏康缘瑞翱生物医药科技有限公司 | 一种重组新城疫病毒rNDV-OX40L、其基因组、制备方法及其用途 |
| US20220396809A1 (en) * | 2021-06-03 | 2022-12-15 | University Of Guelph | Engineered newcastle disease virus vector and uses thereof |
| WO2024167866A2 (en) * | 2023-02-06 | 2024-08-15 | Cyanvac Llc | Modified piv5 vaccine vectors: methods of making and uses |
| WO2025116613A1 (ko) * | 2023-11-29 | 2025-06-05 | 주식회사 카브 | 재조합 뉴캣슬병 바이러스 벡터를 포함하는 암 치료용 약제학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7724558B1 (en) * | 1999-03-19 | 2010-05-25 | Nec Corporation | Magnetic signal transmission line |
| EP1217891B1 (en) * | 1999-09-24 | 2009-12-16 | Mayo Foundation For Medical Education And Research | Therapeutic methods and compositions using viruses of the recombinant paramyxoviridae family |
| KR100801180B1 (ko) * | 2006-09-26 | 2008-02-05 | 주식회사 고려비엔피 | 약독화된 재조합 뉴캐슬병 바이러스 및 이를 함유하는뉴캐슬병 백신 |
| EP2085092A1 (en) | 2008-01-29 | 2009-08-05 | Bayer Schering Pharma Aktiengesellschaft | Attenuated oncolytic paramyxoviruses encoding avian cytokines |
| US20090208495A1 (en) | 2008-02-14 | 2009-08-20 | Bayer Schering Pharma Ag | Anti-tumor effective paramyxovirus |
| ES2550179T3 (es) * | 2009-02-05 | 2015-11-05 | Icahn School Of Medicine At Mount Sinai | Virus quiméricos de la enfermedad de Newcastle y usos de los mismos |
| NZ711946A (en) * | 2013-03-14 | 2020-05-29 | Icahn School Med Mount Sinai | Newcastle disease viruses and uses thereof |
| EA039404B1 (ru) * | 2013-09-03 | 2022-01-24 | Медиммун Лимитед | Аттенуированный вирус ньюкаслской болезни (ndv) штамма 73т для лечения неоплазии, способ селективного цитолиза опухолевых клеток и способ индуцирования регресса опухоли с его использованием |
| CN109099045A (zh) * | 2018-10-30 | 2018-12-28 | 浙江斯泰新材料科技股份有限公司 | 防松锁固型螺钉 |
-
2014
- 2014-09-02 EA EA201690425A patent/EA039404B1/ru unknown
- 2014-09-02 RS RS20220481A patent/RS63291B1/sr unknown
- 2014-09-02 AU AU2014317215A patent/AU2014317215C1/en active Active
- 2014-09-02 PL PL14761317T patent/PL3041490T3/pl unknown
- 2014-09-02 EP EP18188565.8A patent/EP3508209B1/en active Active
- 2014-09-02 EA EA202191926A patent/EA202191926A3/ru unknown
- 2014-09-02 KR KR1020167008307A patent/KR102285894B1/ko active Active
- 2014-09-02 HK HK17105137.4A patent/HK1231393A1/zh unknown
- 2014-09-02 PT PT181885658T patent/PT3508209T/pt unknown
- 2014-09-02 SM SM20220214T patent/SMT202200214T1/it unknown
- 2014-09-02 EP EP14761317.8A patent/EP3041490B1/en active Active
- 2014-09-02 US US14/916,102 patent/US10519426B2/en active Active
- 2014-09-02 ES ES18188565T patent/ES2914577T3/es active Active
- 2014-09-02 CA CA2922071A patent/CA2922071C/en active Active
- 2014-09-02 LT LTEP14761317.8T patent/LT3041490T/lt unknown
- 2014-09-02 EP EP22160157.8A patent/EP4101457A1/en not_active Withdrawn
- 2014-09-02 PL PL18188565T patent/PL3508209T3/pl unknown
- 2014-09-02 KR KR1020217012332A patent/KR102310692B1/ko active Active
- 2014-09-02 CN CN202010064863.0A patent/CN111944767A/zh active Pending
- 2014-09-02 CN CN201480048630.4A patent/CN106163532B/zh active Active
- 2014-09-02 LT LTEP18188565.8T patent/LT3508209T/lt unknown
- 2014-09-02 HR HRP20190250TT patent/HRP20190250T1/hr unknown
- 2014-09-02 ES ES14761317T patent/ES2708755T3/es active Active
- 2014-09-02 RS RS20190176A patent/RS58332B1/sr unknown
- 2014-09-02 HU HUE14761317A patent/HUE042382T2/hu unknown
- 2014-09-02 HR HRP20220653TT patent/HRP20220653T1/hr unknown
- 2014-09-02 TR TR2019/02073T patent/TR201902073T4/tr unknown
- 2014-09-02 SI SI201431082T patent/SI3041490T1/sl unknown
- 2014-09-02 WO PCT/EP2014/068619 patent/WO2015032755A1/en not_active Ceased
- 2014-09-02 ME MEP-2019-40A patent/ME03345B/me unknown
- 2014-09-02 SI SI201431957T patent/SI3508209T1/sl unknown
- 2014-09-02 SM SM20190094T patent/SMT201900094T1/it unknown
- 2014-09-02 DK DK14761317.8T patent/DK3041490T3/en active
- 2014-09-02 HK HK16114099.3A patent/HK1225643B/en unknown
- 2014-09-02 JP JP2016537333A patent/JP6557234B2/ja active Active
- 2014-09-02 DK DK18188565.8T patent/DK3508209T3/da active
- 2014-09-02 PT PT14761317T patent/PT3041490T/pt unknown
- 2014-09-02 MX MX2016002771A patent/MX367768B/es active IP Right Grant
- 2014-09-03 TW TW103130466A patent/TWI653334B/zh active
-
2016
- 2016-03-02 MX MX2019010364A patent/MX2019010364A/es unknown
-
2019
- 2019-02-08 CY CY20191100170T patent/CY1121993T1/el unknown
- 2019-06-24 AU AU2019204419A patent/AU2019204419B2/en active Active
- 2019-07-11 JP JP2019129161A patent/JP6862500B2/ja not_active Expired - Fee Related
- 2019-11-14 US US16/684,241 patent/US11471499B2/en active Active
-
2022
- 2022-05-25 CY CY20221100362T patent/CY1126790T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019193662A5 (enExample) | ||
| JP2016533749A5 (enExample) | ||
| HRP20220653T1 (hr) | Sastavi koji sadrže oslabljeni virus newcastleske bolesti i postupci uporabe za liječenje neoplazije | |
| CN106795527B (zh) | 溶瘤病毒 | |
| JP2014506913A5 (enExample) | ||
| JP2019511483A5 (enExample) | ||
| JP2019508403A5 (enExample) | ||
| Alemany | Viruses in cancer treatment | |
| JPWO2021183564A5 (enExample) | ||
| RU2018146490A (ru) | Новые генно-инженерные вирусы осповакцины | |
| CN110603048A (zh) | 细胞因子组合 | |
| JP2016531927A5 (enExample) | ||
| HRP20191972T1 (hr) | Pripravci i postupci za aktiviranje signalizacije ovisne o "stimulatoru gena interferona" | |
| JP2019533015A5 (enExample) | ||
| JP2018512150A5 (enExample) | ||
| JP2014207903A5 (enExample) | ||
| RU2017134519A (ru) | Терапевтические композиции и способы применения для лечения рака | |
| KR20100122482A (ko) | 항종양 효과가 있는 파라믹소바이러스 | |
| JP2012162567A5 (enExample) | ||
| JP2020505046A5 (enExample) | ||
| JP2020528890A (ja) | 腫瘍を治療するためのウイルス | |
| JP2019038797A5 (enExample) | ||
| Lundstrom | Latest trends in cancer therapy applying viral vectors | |
| WO2009120306A1 (en) | Multivalent vaccine vector for the treatment and inhibition of viral infection | |
| CN115804853A (zh) | 包含rna分子的组合物及其在制备瘤内注射剂中的用途 |